Trials / Completed
CompletedNCT01016782
Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea
Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study of 0444 Gel
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 867 (actual)
- Sponsor
- Fougera Pharmaceuticals Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the Treatment of Inflammatory Lesions of Rosacea. Treatment medication will be administered as follows: A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0444 | A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-11-19
- Last updated
- 2014-07-04
Source: ClinicalTrials.gov record NCT01016782. Inclusion in this directory is not an endorsement.